Skip to main content
Caplight Logo









Morphle Labs

Morphle Labs

Private
BangaloreHealthcare & Life Scienceshttps://morphlelabs.com/

Last Round

Series A

Nov 25, 2025

Est. Valuation

$1.79M

Total Funding Raised

$10.2M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Morphle Labs is a medical device company that develops AI-powered robotic microscopes and digital pathology scanners to automate tissue processing and slide scanning for cancer diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI, Industrial Robotics

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

digital pathologyrobotic microtomewhole slide imagingtelepathologymedical imaginghistopathologylab automationcancer diagnosticsmedical AIpathology scannerpathology lab automationsmart labmedical deviceAI diagnosticspathology workflow

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Morphle Labs Comparables

Compare Morphle Labs with similar companies based on industry and business-model similarity.

Morphle Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Clarapath
83%
OptraSCAN
81%
Grundium
77%

Morphle Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ANov 25, 2025
Series ANov 25, 2023
SeedMar 17, 2020
GrantDec 16, 2019

Key People

Founding team and executive leadership

Rohit Hiwale

Founder CEO

Founding Team

Sunnel Daniel

Chief Operating Officer, Vice President Of Sales

Executive Team

Morphle Labs Investors

Notable investors and investment history

Morphle Labs investors
InvestorRounds
Enzia VenturesSeed
HealthVentureGrant
Y CombinatorSeed
Inflexor VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 64% MoM, reaching 9.9K.

  • Dec 5, 2025

    Claims market leadership in India with global customer growth.

Morphle Labs Filings

Explore SEC and related filing metadata, where available.

Morphle Labs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Morphle Labs's valuation, stock price, and market status.

Is Morphle Labs a public or private company?

Morphle Labs is a private company.

What is the current stock price of Morphle Labs?

Morphle Labs is a private company with no public stock price. No recent secondary market data is available.

How much is Morphle Labs worth (valuation)?

Valuation information for Morphle Labs is not publicly available.

Can I buy Morphle Labs stock?

Morphle Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Morphle Labs's last funding round?

Morphle Labs's most recent funding round was Series A on November 25, 2025.

Who are the main investors in Morphle Labs?

Key investors in Morphle Labs include Y Combinator, Inflexor Ventures.

Will Morphle Labs IPO soon?

No public IPO plans have been announced for Morphle Labs.

How can I track Morphle Labs secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Morphle Labs's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBangalore
Employee Range92
Year Founded2017
Last FundingNov 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?